Burkavage Brian 4
4 · IO Biotech, Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Burkavage Brian
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-31+20,000→ 20,000 totalExercise: $4.83Exp: 2032-05-31→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on 5/31/2023, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.